RP
Rahul Pratap Singh
About Rahul Pratap Singh
Data last updated:
Rahul Pratap Singh is a Director at Kosee Pharma Private Limited (since 2013). The companies operate in Trading. Kosee Pharma Private Limited reported revenue of ₹85.8 Lakh (FY 2025). Earlier, Rahul Pratap Singh was a Director at Frigate Life Sciences Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jun 2013 | 2013 | ₹85.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Nov 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahul Pratap Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dheeraj Kumar Pandey | 02951070 | Kosee Pharma Private Limited | Director |
| Geeta Singh | 05127121 | Kosee Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Pratap Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Pratap Singh
Rahul Pratap Singh currently holds 1 directorship: Kosee Pharma Private Limited (Director, since 07 Jun 2013, revenue ₹85.8 Lakh (FY 2025)).
Rahul Pratap Singh was first appointed on 30 Nov 2011 as Director at Frigate Life Sciences Private Limited. The most recent appointment on record is 07 Jun 2013 at Kosee Pharma Private Limited.
Rahul Pratap Singh held 1 earlier board appointment: Frigate Life Sciences Private Limited (Director, from 30 Nov 2011).
The current boards of Rahul Pratap Singh's companies include Dheeraj Kumar Pandey (Kosee Pharma Private Limited), Geeta Singh (Kosee Pharma Private Limited).